Literature DB >> 16310600

Prevalence, incidence, and risk factors for venous thromboembolism in medical-surgical intensive care unit patients.

Deborah J Cook1, Mark A Crowther, Maureen O Meade, Jim Douketis.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16310600     DOI： 10.1016/j.jcrc.2005.09.005

Source DB:  PubMed          Journal:  J Crit Care        ISSN： 0883-9441            Impact factor:   3.425


× No keyword cloud information.
  8 in total

1.  Coagulation Day 2010: an Austrian survey on the routine of thromboprophylaxis in intensive care.

Authors:  E Schaden; P G Metnitz; G Pfanner; S Heil; T Pernerstorfer; P Perger; H Schoechl; D Fries; M Guetl; S Kozek-Langenecker
Journal:  Intensive Care Med       Date:  2012-03-24       Impact factor: 17.440

Review 2.  The impact of deep vein thrombosis in critically ill patients: a meta-analysis of major clinical outcomes.

Authors:  Alessandra Malato; Francesco Dentali; Sergio Siragusa; Francesco Fabbiano; Yoan Kagoma; Maria Boddi; Gian Franco Gensini; Adriano Peris; Mark Crowther; Mariasanta Napolitano
Journal:  Blood Transfus       Date:  2015-10       Impact factor: 3.443

3.  Upsurge of deep venous thrombosis in patients affected by COVID-19: Preliminary data and possible explanations.

Authors:  Enrico M Marone; Luigi F Rinaldi
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2020-04-17

Review 4.  Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review.

Authors:  Subarna Thirugnanam; Ruxandra Pinto; Deborah J Cook; William H Geerts; Robert A Fowler
Journal:  Crit Care       Date:  2012-03-09       Impact factor: 9.097

5.  Incidence of proximal deep vein thrombosis in medical critical care patients.

Authors:  Chairat Permpikul; Walailak Chaiyasoot; Anupol Panitchote
Journal:  Thromb J       Date:  2022-02-05

Review 6.  Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.

Authors:  Damiano D'Ardes; Andrea Boccatonda; Giulio Cocco; Stefano Fabiani; Ilaria Rossi; Marco Bucci; Maria Teresa Guagnano; Cosima Schiavone; Francesco Cipollone
Journal:  World J Gastroenterol       Date:  2022-03-21       Impact factor: 5.742

7.  Antifactor Xa levels in critically ill Korean patients receiving enoxaparin for thromboprophylaxis: a prospective observational study.

Authors:  So Yeon Lim; Kyeongman Jeon; Hee-Jin Kim; Seon Mi Kim; Junwhi Song; Jung Min Ha; Sang-Won Um; Won-Jung Koh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Gee Young Suh
Journal:  J Korean Med Sci       Date:  2013-03-04       Impact factor: 2.153

Review 8.  Thrombotic complications of COVID-19.

Authors:  Jacob Avila; Brit Long; Dallas Holladay; Michael Gottlieb
Journal:  Am J Emerg Med       Date:  2020-10-01       Impact factor: 4.093
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.